comparison of escitalopram and venlafaxine in first episode depressio
Not Applicable
Completed
- Conditions
- Health Condition 1: null- first episode unipolar depression
- Registration Number
- CTRI/2017/11/010347
- Lead Sponsor
- GMCH chandigarh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1. Patients of unipolar depression as per ICD-10. 2. Treatment naive patients.
3. Patients in the age group of 18-55 years.
4. Patients willing to participate in study.
5. Patients with reliable informant
Exclusion Criteria
1. Patients of bipolar depression and recurrent depressive disorder.
2. Patients with Severe depressive episode with psychotic symptoms.
3. Patients with co-morbid substance related disorders except nicotine & caffeine.
4. Patients with subnormal intelligence.
5. Pregnant and lactating patients.
6. Any history of medical, surgical neurological complication/cognitive impairment or any other condition in which these medications are contraindicated.
7. Actively Suicidal patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response with the minimum therapeutic dosage of the moleculeTimepoint: 2 weeks
- Secondary Outcome Measures
Name Time Method assessment of response side effects and effect on cognition and quality of life with both the moleculesTimepoint: 3 months